Verastem (FRA:2VSA) Other Gross PPE : €0.97 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Verastem Other Gross PPE?

Verastem's Other Gross PPE for the quarter that ended in Mar. 2024 was €0.97 Mil.

Verastem's quarterly Other Gross PPE declined from Sep. 2023 (€1.29 Mil) to Dec. 2023 (€1.22 Mil) and declined from Dec. 2023 (€1.22 Mil) to Mar. 2024 (€0.97 Mil).

Verastem's annual Other Gross PPE declined from Dec. 2021 (€2.17 Mil) to Dec. 2022 (€1.83 Mil) and declined from Dec. 2022 (€1.83 Mil) to Dec. 2023 (€1.22 Mil).

Verastem Other Gross PPE Historical Data

The historical data trend for Verastem's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verastem Other Gross PPE Chart

Verastem Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

2.90

2.36

2.17

1.83

1.22

Verastem Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Gross PPE	Get a 7-Day Free Trial															1.59	1.42	1.29	1.22	0.97

Verastem Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Verastem (FRA:2VSA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verastem Inc (FRA:2VSA) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

VSTM:USA 2VS:Germany

Address

117 Kendrick Street, Suite 500, Needham, MA, USA, 02494

Website

https://www.verastem.com

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Verastem (FRA:2VSA) Headlines

No Headlines